Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 218 entries
View as:

Safety and Efficacy of LEO 80185 Gel in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01120223 Org: User:
Start: 05/31/10 End: 10/31/12 Due: 10/31/13

A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis

Phase: N/A Priority: Normal
NCT ID: NCT01922050 Org: User:
Start: 10/31/13 End: 11/30/14 Due: 11/30/15

Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT03806790 Org: User:
Start: 01/24/19 End: 06/10/19 Due: 06/10/20

Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE)

Phase: N/A Priority: Normal
NCT ID: NCT03099031 Org: User:
Start: 05/31/15 End: 05/15/17 Due: 05/15/18

Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT00817219 Org: User:
Start: 07/31/09 End: 12/31/11 Due: 12/31/12

Combined Cumulative Irritation Potential and Repeat Insult Patch Test of LEO 90100

Phase: N/A Priority: Normal
NCT ID: NCT01935869 Org: User:
Start: 08/31/13 End: 12/31/13 Due: 12/31/14

Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamics Effect of Calcipotriol/Betamethasone Dipropionate in a New Administration Form in Subjects With Chronic Plaque Psoriasis.

Phase: N/A Priority: Normal
NCT ID: NCT03898583 Org: User:
Start: 04/15/19 End: 10/29/19 Due: 10/29/20

A Psoriasis Plaque Test Trial With LEO 90100 Compared to Betesil® in Patients With Psoriasis Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT02518048 Org: User:
Start: 08/31/15 End: 01/31/16 Due: 01/31/17

Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab

Phase: N/A Priority: Normal
NCT ID: NCT04533737 Org: User:
Start: 12/17/20 End: 12/07/22 Due: 12/07/23

LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02668692 Org: User:
Start: 02/29/16 End: 06/30/16 Due: 06/30/17

A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the Face

Phase: N/A Priority: Normal
NCT ID: NCT00408330 Org: User:
Start: 12/31/06 End: 03/31/07 Due: 03/31/08

PMS to Evaluate the Safety and Efficacy of Picato® Gel

Phase: N/A Priority: Normal
NCT ID: NCT02421471 Org: User:
Start: 09/30/14 End: 01/19/18 Due: 01/19/19

Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects by Dermal Application of a LEO 29102

Phase: N/A Priority: Normal
NCT ID: NCT01423656 Org: User:
Start: 08/31/11 End: 11/30/12 Due: 11/30/13

Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Gel, 0.05%

Phase: N/A Priority: Normal
NCT ID: NCT01892137 Org: User:
Start: 07/31/13 End: 05/31/14 Due: 05/31/15

Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1)

Phase: N/A Priority: Normal
NCT ID: NCT05388760 Org: User:
Start: 09/07/22 End: 04/23/26 Due: 04/23/27

A Clinical Study to Evaluate the Sensitizing Potential of LEO 43204 Gel

Phase: N/A Priority: Normal
NCT ID: NCT02650505 Org: User:
Start: 02/29/16 End: 06/30/16 Due: 06/30/17

A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp

Phase: N/A Priority: Normal
NCT ID: NCT03115476 Org: User:
Start: 06/16/17 End: 03/12/18 Due: 03/12/19

Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel)

Phase: N/A Priority: Normal
NCT ID: NCT01052467 Org: User:
Start: 01/31/10 End: 05/31/10 Due: 05/31/11

Patient Insights Following Use of LEO 90100 Aerosol Foam and Daivobet® Gel in Subjects With Psoriasis Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT02310646 Org: User:
Start: 01/31/15 End: 07/31/15 Due: 07/31/16

Pharmacokinetics of Ingenol Mebutate Gel in Actinic Keratosis Under Maximum Use Conditions

Phase: N/A Priority: Normal
NCT ID: NCT02124239 Org: User:
Start: 04/30/14 End: 11/30/14 Due: 11/30/15

Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts

Phase: N/A Priority: Normal
NCT ID: NCT02377999 Org: User:
Start: 02/28/15 End: 11/30/15 Due: 11/30/16

Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment Compared With Tacalcitol Ointment in Patients With Psoriasis on the Face and Skin Folds

Phase: N/A Priority: Normal
NCT ID: NCT00640822 Org: User:
Start: 02/29/08 End: 07/31/09 Due: 07/31/10

LEO 22811 - Single Dose Bioavailability Study of Tablet Versus Oral Solution in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01211964 Org: User:
Start: 09/30/10 End: 12/31/10 Due: 12/31/11

A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema

Phase: N/A Priority: Normal
NCT ID: NCT05259722 Org: User:
Start: 06/15/22 End: 12/05/23 Due: 12/05/24

A Phase I Study With LEO 32731 and Midazolam in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02753218 Org: User:
Start: 04/30/16 End: 05/31/16 Due: 05/31/17